NIAID is always accepting researcher-initiated applications. Connect with NIAID program officers about potential funding for STI research.

Program Officers

Program Officers for STIs can be found in the Enteric and Sexually Transmitted Infections Branch (ESTIB) of the Division of Microbiology and Infectious Diseases (DMID). For information on HSV basic research, see DMID's Virology Branch (VB).

Researchers at NIAID

Explore the list of laboratory scientists doing STI research at NIAID as well as researchers focusing specifically on HIV/AIDS.

Social Media

NIAID provides a wide range of resources for every stage of the development pathway to facilitate and advance infectious disease research. These include repositories, genomics and bioinformatics services and tools, preclinical studies, and clinical trials. You may request services if you are an investigator in academia, a not-for-profit organization, industry, or government in the United States or worldwide. You need not be a grantee of NIAID or another National Institutes of Health Institute or Center. Look to each resource for further eligibility information.

Past Meetings

Current Challenges in Evaluating Antimicrobials for Urogenital Gonorrhea
Experts Collaborate to Design Thorough and Effective Future Trials
February 5-6, 2019

Contact the Parasitology and International Programs Branch (PIPB) within the Division of Microbiology and Infectious Diseases to learn about possible funding opportunities.

Search for scientists at NIAID who research malaria in the scientist directory.

Search for scientists funded by NIAID who research malaria on RePORTER.

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. Look to each resource for eligibility information. See all resources for malaria researchers. 

For researchers developing products such as diagnostics, vaccines, or drug therapies, check out NIAID's support for infectious disease product developers.

NIAID encourages partnerships among other agencies and foundations, private industry, federal and local government and other organizations with similar goals to help build and sustain research infrastructure and to translate and implement research findings as public health practices.

For example, the NIAID-funded International Centers of Excellence for Malaria Research are a global network of centers in malaria-endemic areas conducting multidisciplinary research on the parasite, mosquito vector, and human host factors responsible for malaria.

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for tickborne disease researchers. 

For researchers developing products such as diagnostics, vaccines, or drug therapies, NIAID provides repositories, genomics and bioinformatics services and tools, preclinical studies, and clinical evaluation that support each stage of the product development pathway. Read more about NIAID's support for infectious disease product developers.

Contact the following staff within the Division of Microbiology and Infectious Diseases to learn about possible funding opportunities:

• Dr. Sam Perdue, Chief, Basic Sciences Section, Rickettsial and Related Diseases Program Officer, Bacteriology and Mycology Branch
• Dr. Nadine Bowden, Lyme Disease Program Officer, Bacteriology and Mycology Branch
• Dr. Adriana Costero-Saint Denis, Program Officer, Vector Biology, Parasitology and International Programs Branch

• Incorporating Systems Biology to Vector-Borne Pathogen Research: Current Landscape, Challenges, and Opportunities, May 17–18, 2022
• Targeting the Parasite within the Vector: Exploring Novel Approaches to Prevent Transmission of Vector-Borne Diseases, July 20-21, 2021
• Driving Success in Vector Control Product Development for Public Health: The Critical Roles of Preferred Product Characteristics (PPC) and Target Product Profile (TPP) Documents, June 26, July 2, and August 6, 2020
• Vector Control Product Development Pathway: Phase-Dependent Evidence Gathering, June 24-25, 2019
• A Primer For The Design And Conduct Of Clinical Trials For Vector Interventions, May 7-8, 2018

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services developed in its labs to the general scientific community for the advancement of biomedical research.

Search for scientists at NIAID who research lyme disease in the scientist directory.

Search for scientists funded by NIAID who research lyme disease on RePORTER.
 

NIAID offers resources, information about funding, and ways to connect to other scientists researching tickborne diseases including lyme disease.

NIAID is funding research on HIV/AIDS, including developing and testing preventive HIV vaccines, prevention strategies, and new treatments for HIV infection and associated coinfections, co-morbidities, and complications.

NIAID offers resources such as technology for licensing or collaboration, computer applications, and other tools and services developed in its labs to the general scientific community for the advancement of biomedical research.

NIAID encourages partnerships among other agencies and foundations, private industry, federal and local government and other organizations with similar goals to help build and sustain research infrastructure and to translate and implement research findings as public health practices.

Such partnerships ensure that the research will lead to findings that are ultimately feasible and meaningful for impacted communities. NIAID is deeply committed to local and international research collaboration that are mutually beneficial and scientifically productive.

For decades NIAID had supported the separate Multicenter AIDS Cohort Study (MACS) and Women's Interagency HIV Study (WIHS) cohort studies. MACS was a study of gay and bisexual men, while WIHS was a study of women who had other risk factors for HIV.

In 2019, the National Heart, Lung, and Blood Institute (NHLBI) became the primary steward of the new MACS/WIHS-CSS. For this effort, the NHLBI is working in close collaboration with the NIH Office of AIDS Research (OAR) as well as several co-funding institutes across the NIH.

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services developed in its labs to the general scientific community for the advancement of biomedical research.

Search for scientists at NIAID who research food allergy in the scientist directory.

Search for scientists funded by NIAID who research food allergy on RePORTER. 

NIAID supports a spectrum of research, from basic studies in allergy and immunology to food allergy clinical trials. Through these efforts, NIAID-funded scientists and clinicians are making significant progress in combating food allergies that affect millions of children and adults worldwide.

Atopic Dermatitis Research Network scientists aim to understand immune system responses in the skin by comparing responses to viral and bacterial skin infections in healthy individuals with those in people with atopic dermatitis.

NIAID is always accepting researcher-initiated applications. Connect with one of the NIAID program officers working in your area of research listed below about potential or related funding for Ebola virus and Marburg virus research.

Virology Branch

• Dr. Jean Patterson, Acting Chief
• Dr. Kaitlyn Morabito, Section Chief, Basic Research
• Dr. Les Dupuy, Program Officer, Alphaviruses and Filoviruses
• Dr. Mindy Davis, Acting Section Chief, Translational Research
• Dr. Sara Woodson, Team Lead, Centers for Research in Emerging Infectious Diseases (CREID) Network

Office of Biodefense, Research Resources and Translational Research

• Dr. Paula Bryant, Director
• Dr. Judy Hewitt, Deputy Director
• Dr. Ann Eakin, Senior Scientific Officer, Concept Acceleration Program (Therapeutics) 
• Dr. Paul Eder, Senior Scientific Officer, Concept Acceleration Program (Diagnostics) 
• Dr. Kim Taylor, Senior Scientific Officer, Concept Acceleration Program (Vaccines)

• The NIAID-funded Centers of Excellence for Translational Research program is funding innovative research to develop novel therapeutics and vaccines against Ebola and Marburg viruses. Filovirus research is also supported through the National Biocontainment Research Facilities.
• NIAID funds the Centers for Research in Emerging Infectious Diseases (CREID), a global network of multidisciplinary investigations into how and where viruses and other pathogens can emerge from wildlife and spillover to cause disease in people. Research is led by 10 Centers and one Coordinating Center and involves collaborations with peer institutions in the United States and 28 other countries. 

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for Ebola and Marburg researchers.

For researchers developing products such as diagnostics, vaccines, or drug therapies, check out NIAID's support for infectious disease product developers.

Search for scientists at NIAID who research ebola and marburg in the scientist directory. The Integrated Research Facility also does research on Ebola and Marburg.

Search for scientists funded by NIAID who research malaria on RePORTER.

NIAID offers resources such as technologies available for licensing or collaboration, computer applications, and other tools and services to the general scientific community to advance basic, preclinical, and clinical research. See all resources for coronavirus researchers. 

For researchers developing products such as diagnostics, vaccines, or drug therapies, NIAID provides repositories, genomics and bioinformatics services and tools, preclinical studies, and clinical evaluation that support each stage of the product development pathway. Read more about NIAID's support for infectious disease product developers.

Also, visit the NIH COVID-19 website for additional resources from other NIH Institutes and Centers.

• To find grant funding opportunities specific to COVID-19, search for COVID on our Opportunities page.
• You may consider other funding opportunities that allow you to propose COVID-19 research, for example, Parent Program Announcements.
• To find all NIAID contract funding opportunities, see contract solicitations.

For the latest information, read recent NIAID Funding News articles.

You can also check out special announcements that will keep you up-to-date on other NIAID-relevant NIH Guide notices.

Request Access to NIAID COVID-19 Clinical Trials Data Sets

AccessClinicalData@NIAID is an NIAID cloud-based, secure data platform that enables sharing of and access to data sets from NIAID COVID-19 clinical trials for the basic and clinical research community. Read more about AccessClinicalData@NIAID.

Other Opportunities for Shared Data

The Seattle Structural Genomics Center for Infectious Diseases and Center for Structural Genomics of Infectious Diseases are making their data publicly available. See more information about the Centers for Research on Structural Biology of Infectious Diseases (CRSTAL-ID) in general.

The COVID-19 Scientific Interest Group was created to promote collaboration and facilitate the exchange of information and resources among NIH intramural scientists and their HHS colleagues concerning research on COVID-19 and SARS-CoV-2.

Search for scientists at NIAID who research coronaviruses in the scientist directory.

Search for scientists funded by NIAID who research coronaviruses on RePORTER.

NIH currently recommends that laboratories working with SARS-CoV-2 adhere to the Centers for Disease Control and Prevention (CDC) interim laboratory biosafety guidelines for collecting and handling specimens potentially containing SARS-CoV-2. In addition, all research subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines) must be reviewed and approved by an Institutional Biosafety Committee (IBC).

Get additional information about the NIH Guidelines and IBCs.

Questions related to the NIH Guidelines may be addressed to NIHGuidelines@od.nih.gov. 

NIAID researchers are spearheading a large, international collaboration to investigate the innate and adaptive immune responses during acute COVID-19 infection and convalescence. The overall goal is to identify immunological and virological correlates and predictors of clinical outcomes. Researchers are currently seeking physicians to collaborate.